Clinical Trial Search Results

Click on the name (title) to see the trial details in the LRG database. You will also have the opportunity to access trial site data later. Trials are sorted so that trials that are only for GIST appear first. Trials are also sorted so that trials in later phases sort higher on the list. The LRG uses ClinicalTrials.gov and other sources to compile the LRG Clinical Trials database.

2 trials found

Crenolanib besylate

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Phase:   3
 
Drug Category:  D842V
Conditions: Gastrointestinal Stromal Tumor
Treatment Phase: Gleevec-resistant
Status:  Recruiting
Site
City
State
Country
Sarcoma Oncology Center Santa Monica CA USA
Knight Cancer Institute at Oregon Health Sciences University (OHSU) Portland OR USA
Fox Chase Cancer Center Philadelphia PA USA
MD Anderson Cancer Center Houston TX USA
Duke Cancer Institute Durham NC USA
University of Miami, Sylvester Comprehensive Cancer Center Miami FL USA
Johns Hopkins Sidney Kimmel Comp Cancer Center Baltimore MD USA
Institut Bergonie Bordeaux Gironde France
Centre Oscar Lambret - Lille Lille Nord France
Centre Léon Bérard Lyon Rhone France
Hospital de La Timone Marseille France
Centre Val d'Aurele Montpellier France
CHU de Reimes - Hôpital Pontchaillou Reimes France
Institut Gustave Roussy Villejuif Val de Narne France
Helios Klinikum Berlin-Buch Berlin Germany
Universistatsklinikum Mannheim Mannheim Germany
Klinikum der Universitaet Muenchen-Grosshadem Campus Munich Germany
Istituto Nazionale Dei Tumori Milan Italy
Norwegian Radium Hospital Oslo Norway
Centrum Onkologii - Instytut Im. Sklodowskiej-Curie w Warszawie Warsaw Poland
Hospital Vall d'Hebron Barcelona Spain
Hospital Universitario Puerta de Hierro de Majadahonda Madrid Spain
Cambridge University Hospitals Cambridge UK
Royal Marsden Hospital - Chelsea London UK
Policlinico S. Orsola-Malpighi Bologna Italy
Institut Regina Elena / IFO Rome Italy
Candiolo Cancer Institute - FPO, IRCCS Turin Italy
Hospital Virgen del Rocio Sevilla Spain
Fundación Instituto Valenciano de Oncología Valencia Spain
Sheffield Teaching Hospital Sheffield UK


Avapritinib

Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors
Phase:   1
 
Drug Category:  KIT/PDGFRA inhibitor + D842V inhibitor
Conditions: Gastrointestinal Stromal Tumor
Treatment Phase: Gleevec-resistant
Status:  Recruiting
Site
City
State
Country
Dana Farber Cancer Institute Boston MA USA
Fox Chase Cancer Center Philadelphia PA USA
Oregon Health & Science University Portland OR USA
Leuven Cancer Institute, Catholic University Leuven Leuven Belgium
Erasmus Medical center Rotterdam Netherlands
Universitatsklinikum Essen, West Germany Cancer Center Essen Germany
Centre Léon Bérard Lyon Rhone France
Royal Marsden Hospital - Chelsea London UK
Institut Gustave Roussy Villejuif Val de Narne France
University of Miami, Sylvester Comprehensive Cancer Center Miami FL USA
Memorial Sloan-Kettering Cancer Center New York NY USA
Istituto Nazionale Dei Tumori Milan Italy
Asan Medical center Seoul Songpa-gu Republic of Korea
Centrum Onkologii - Instytut Im. Sklodowskiej-Curie w Warszawie Warsaw Poland
Hospital Vall d'Hebron Barcelona Spain
MD Anderson Cancer Center Houston TX USA
Sarcoma Oncology Center Santa Monica CA USA


2 trials found